Prospective studies carried out in recent years have shown that when prescribed as monotherapy with serum anticonvulsant level monitoring, both carbamazepine and phenytoin are effective in the control of patients with generalised and partial seizures.'-' Sodium valproate has been shown to have an anticonvulsant effect in animals and man.5 It has been found to be effective when added to other anticonvulsant drugs and as monotherapy.6 Sodium valproate, prescribed as monotherapy has been compared with phenytoin,89 and with ethosuximide." ' We report the results of a prospective comparative study carried out between carbamazepine, phenytoin and sodium valproate in previously untreated patients with a recent diagnosis of epilepsy. A preliminary report has already been published." Methods Carbamazepine, sodium valproate and phenytoin were prescribed on a randomised basis for previously untreated recently diagnosed patients with generalised or partial seizures who had had a minimum of two seizures over a six months period prior to the referral for assessment.
An electroencephalogram was carried out on all patients, but the classification into generalised or partial seizures was based on a clinical assessment of each patient.
Patients were allocated to a generalised seizure group when there was no clinical evidence of a focal association with the seizure. The randomisation procedure which was set up by a statistician was planned as follows. Each patient was allocated three drugs on the basis of a drug of first, second and third preference for each patient. In the randomisation list, carbamazepine was indicated as drug A, sodium valproate as drug B and phenytoin as drug C. The randomisation was based on two latin squares in order to balance the order of treatments. The randomisation procedure was not stratified for age, sex or type of seizure. When a patient was selected for the study, the drug of first preferance was selected on a sequential basis from the randomisation list by the secretary in the department of neurology. If a patient did not respond to the initial dose prescribed for that drug the dose was increased and monitored with blood levels. Patients were seen initially one month after the drug was prescribed and at intervals of one to three months thereafter, depending upon response to treatment. Assessments were carried out at an afternoon seizure clinic. At each visit, response to treatment and side effects were documented, and a specimen of blood was taken for estimation of serum anticonvulsant drug levels. The patients were instructed to take the drug twice daily. If the patient did not achieve complete freedom from seizures or at least a greater than 50% reduction in seizure frequency with high optimal serum levels of the drug of first preference, the dose of that drug was decreased by 200 mg decrements of sodium valproate and carbamazepine and by 100 mg decrements of phenytoin at two weekly intervals, and the drug of second preference allocated from the 639 The classification of seizures is based on the Gastaut 1969 International Classification. '4 Results One hundred and eighty one patients were recruited to the study (ninety five males, eighty six females). One hundred and two patients had generalised seizures while seventy nine patients had partial seizures. Twenty two patients had complex partial seizures with secondary generalised attacks and twenty eight patiets had complex partial seizures without secondary generalised attacks. Eight patients had simple partial seizures with secondary generalised attacks and twenty one had simple partial seizures without secondary generalised attacks. In twenty two patients, the complex partial seizures were associated with effective symptomatology, 10 patients with psychomotor symptomatology, 12 patients with psychosensory symptomatology, and six patients had cognitive symptomatology. In five patients, the simple partial seizures were associated with autonomic symptoms, 14 patients with motor symptoms and 10 patients with sensory symptoms.
Generalised tonic clonic seizures (without focal features)
The number of patients randomised to the three drugs, the patient ' Poor 17-5 ± 11-9 521-8 ± 185-6
Carbamazepine by control All patients 10-9 ± 6-9 28-7 + 11-5 Excellent 8-6 + 3-1 25-7 + 10-2 A study of monotherapy with carbamazepine, phenytoin and valproate Serum drug levels Drug levels and drug dosage related to seizure control for the three drugs are shown in table 10. Excellent and good control with sodium valproate or carbamazepine was associated with therapeutic blood levels for both drugs. However, excellent or good control in patients taking phenytoin was achieved with sub-therapeutic blood levels. The highest levels for carbamazepine and phenytoin occurred in patients with poor control.
Discontinuation of treatment So far, treatment has been discontinued in 26 patients, eight taking carbamazepine, seven taking valproate and 11 phenytoin. Four patients have relapsed, one taking carbamazepine, two taking phenytoin and one taking sodium valproate.
Discussion
A number of studies based on crossover designs have been carried out to compare carbamazepine with phenytoin in patients with generalised and partial seizures. In these studies both drugs have been found to be effective in the control of generalised '5 16 and partial seizures. '7 18 The results of all these studies are based on short follow up periods. Shakir et al8 19 compared sodium valproate with phenytoin in one group of patients and with carbamazepine in a different group. In the carbamazepine group the findings suggested that both carbamazepine and valproate were equally effective in the control of generalised and partial seizures. In the phenytoin group, the number of patients studied was too small to make a valid comparison, but the findings did suggest that partial seizures were helped by sodium valproate. In this study, all three drugs were found to be effective for the control of both generalised and partial seizures with a better response in patients with generalised attacks. Tumbull eta1920 carried out a prospective study in previously untreated patients to compare phenytoin with sodium valproate. Both drugs were found to be effective for the control of both generalised and partial seizures, but less effective in the control of partial attacks. In previous studies,67 the '-3 and that reduction in polypharmacy can result in improved seizure control.3 23 24 However, when a patient fails to respond to the first drug prescribed as monotherapy, there is still a tendency to prescribe multiple drugs. We have shown that by substituting an alternative drug as monotherapy for patients who have failed to respond to the first drug prescribed, and a third drug as monotherapy when patients fail to respond to the second drug, it was possible to restrict polypharmacy to six patients.
When mean blood levels, based on levels measured on a fixed dose of the drug were evaluated, it was found that with carbamazepine, excellent or good control was achieved with levels within the therapeutic range, while a similar degree of control with phenytoin was achieved with sub-therapeutic levels of the drug. High optimal levels occurred in patients taking carbamazepine or phenytoin in association with poor control and in patients taking valproate in association with good or poor control. The lowest blood levels for all three drugs were found in patients with excellent control, higher levels occurring in patients with good or poor control. This was based on the tendency for the clinician to increase the dose in this group of patients in an attempt to achieve better control.
There was no significant difference between the overall incidence of side effects between the three drugs and with the exception of patients who developed ataxia with toxic levels of phenytoin, we could not detect any correlation between side effects and serum blood levels. There was an association between dosage and drowsiness for carbamazepine and valproate, with improvement in the drowsiness following a reduction in drug dosage. Aggressive behaviour has already been described in children taking sodium valproate,25 but this side effect occurred more frequently when the drug was used in combination with other antiepileptic drugs, in particular, phenobarbitone.
In conclusion, our results show that sodium valproate, carbamazepine and phenytoin are effective in the control of generalised and partial seizures and that all three drugs can be prescribed as an anticonvulsant of first choice. Irrespective of the drug prescribed, partial seizures were less responsive to treatment.
